Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Eoflow (294090 KS)
Watchlist
141
Analysis
Health Care
•
South Korea
Eoflow Co.,Ltd. develops and sells medical devices. The Company produces and sells wearable disposable insulin pumps and other products. Eoflow markets its products throughout Korea.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Eoflow
•
23 Aug 2023 15:32
EOFlow/Medtronic: What Lawsuit?
Trading at a 9.9% gross spread, below where it was trading before the lawsuit. On balance, this Offer gets up. But run the deal specifics via a...
David Blennerhassett
Follow
845 Views
Share
bullish
•
Eoflow
•
21 Aug 2023 01:41
Eoflow's US Subsidiary (Nephria Bio)'s Technology in MXene Advanced Material
This news flow on MXene is likely to put further positive boost to Eoflow's share price closer to the tender offer price (or at least limit further...
Douglas Kim
Follow
795 Views
Share
bullish
•
Costa Group Holdings
•
21 Aug 2023 00:37
Merger Arb Mondays (21 Aug) - Costa, OreCorp, Sanei, T&K Toka, Celltrion, Eoflow, Golden Eagle
This week, the highest gross spreads are 111 (24.9%), Symbio (14.8%), ENM (11.5%), Eoflow (11.1%), Orecorp (9.3%), Mason (9.0%), Costa (7.6%), Poly...
Arun George
Follow
540 Views
Share
bullish
•
Celltrion Inc
•
20 Aug 2023 07:00
(Mostly) Asia-Pac Weekly Risk Arb Wrap: Celltrion, Sanei Architecture, T&K Toka, MPI, Chindata
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
David Blennerhassett
Follow
600 Views
Share
bearish
•
Eoflow
•
14 Aug 2023 00:50
Merger Arb Mondays (14 Aug) - Eoflow, Chindata, OreCorp, Origin, Estia, InvoCare, Daiken, Kyoden
This week, the highest gross spreads are Daiken (28.8%), 111 (20.8%), Eoflow (13.2%), Kyoden (12.6%), Orecorp (10.8%), Symbio (10.7%), ENM (9.4%),...
Arun George
Follow
509 Views
Share
First
Previous
18
19
20
21
22
23
24
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x